Results 61 to 70 of about 12,041 (292)

Thyristor based bridge‐type fault current limiter for fault current limiting capability enhancement

open access: yesIET Generation, Transmission & Distribution, 2016
This study deals with a developed thyristor based bridge‐type fault current limiter (TBFCL), in which the main fault current limiting function is relegated to a limiting circuit controlled by a silicon controlled rectifier (SCR). Since SCR is a reliable power electronic switch and can be found in high ratings, the proposed TBFCL can be utilised in ...
Teymoor Ghanbari   +2 more
openaire   +1 more source

Valosin‐containing protein counteracts ATP‐driven dissolution of FUS condensates through its ATPase activity in vitro

open access: yesFEBS Letters, EarlyView.
Biomolecular condensates formed by fused in sarcoma (FUS) are dissolved by high ATP concentrations yet persist in cells. Using a reconstituted system, we demonstrate that valosin‐containing protein (VCP), an AAA+ ATPase, counteracts ATP‐driven dissolution of FUS condensates through its D2 ATPase activity.
Hitomi Kimura   +2 more
wiley   +1 more source

Fault Ride Through Capability Improvement of DFIG Based Wind Farm Using Nonlinear Controller Based Bridge-Type Flux Coupling Non-Superconducting Fault Current Limiter

open access: yesEnergies, 2020
High penetration of Doubly Fed Induction Generator (DFIG) into existing power grid can attribute complex issues as they are very sensitive to the grid faults.
Md. Rashidul Islam   +6 more
doaj   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Impedance Compensation Method Considering Unbalanced Ground Fault with SFCL in a Power Distribution System

open access: yesEnergies, 2022
As the energy demand increases due to the developing electric power industry, the fault current becomes higher during the fault time. A new approach is needed to reduce a fault current in a power distribution system, since the fault currents influence ...
Yoo-Jung Cho, Sung-Hun Lim
doaj   +1 more source

Analysis of Superconducting Fault Current Limiterin DC System with Renewable Energy Sources [PDF]

open access: yes, 2016
Superconducting fault-current limiters (SFCLs) have been the subject of research and development for many years and offer an attractive solution to the problem of rising fault levels in electrical distribution systems.
Ganesh, C. (C)   +2 more
core  

Experimental study of a transformer with superconducting elements for fault current limitation and energy redistribution

open access: yes, 2005
Numerous proposed and developed superconducting fault current limiters and self-limiting transformers limit successfully fault currents but do not provide uninterrupted supplying of consumers. A design investigated in the work combines the functions of a
Altov   +18 more
core   +1 more source

Frequency and fundamental signal measurement algorithms for distributed control and protection applications [PDF]

open access: yes, 2009
Increasing penetration of distributed generation within electricity networks leads to the requirement for cheap, integrated, protection and control systems.
Burt, G.M.   +2 more
core   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

open access: yesMolecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués   +3 more
wiley   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy